Deirdre Connelly
Chairman bei GENMAB A/S
Vermögen: 2 Mio $ am 31.03.2024
Profil
Derzeit ist Deirdre P. Connelly Vorsitzende von Genmab A. Sie ist auch im Vorstand von Macy's, Inc. und Lincoln National Corp. sowie Direktorin des Public Health Policy Council der Harvard University. Frau Connelly war zuvor President-US Operations bei Eli Lilly & Co. und General Manager-Sales bei Eli Lilly Export S.A. (einer Tochtergesellschaft von Eli Lilly & Co.), President-North American Pharmaceuticals bei GlaxoSmithKline Plc President & Chief Executive Officer für Human Genome Sciences, Inc. und President-North America Pharmaceuticals bei Genelabs Technologies, Inc. (beide sind Tochtergesellschaften von GlaxoSmithKline Plc) und Executive Director-Global Marketing bei Evista Industries, Inc. Frau Connelly erwarb einen Bachelor-Abschluss am Lycoming College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GENMAB A/S
0,01% | 14.02.2024 | 5 750 ( 0,01% ) | 2 Mio $ | 31.03.2024 |
MACY'S, INC.
0,00% | 19.05.2023 | 10 842 ( 0,00% ) | 216 732 $ | 31.03.2024 |
LINCOLN NATIONAL CORP
0,00% | 31.03.2024 | 4 000 ( 0,00% ) | 127 720 $ | 31.03.2024 |
Aktive Positionen von Deirdre Connelly
| Unternehmen | Position | Beginn |
|---|---|---|
| MACY'S, INC. | Director/Board Member | 01.01.2008 |
| LINCOLN NATIONAL CORPORATION | Director/Board Member | 26.05.2016 |
| GENMAB A/S | Chairman | 26.03.2020 |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Deirdre Connelly
| Unternehmen | Position | Ende |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01.02.2015 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Chief Executive Officer | 01.02.2015 |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Corporate Officer/Principal | 01.01.2015 |
| ELI LILLY AND COMPANY | Human Resources Officer | 01.06.2005 |
| Norwest Indiana, Inc. | Director/Board Member | - |
Ausbildung von Deirdre Connelly
| Lycoming College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 5 |
|---|---|
| MACY'S, INC. | Retail Trade |
| ELI LILLY AND COMPANY | Health Technology |
| LINCOLN NATIONAL CORPORATION | Finance |
| GSK PLC | Health Technology |
| GENMAB A/S | Health Technology |
| Private Unternehmen | 6 |
|---|---|
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Health Technology |
Genelabs Technologies, Inc.
Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Health Technology |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Health Technology |
| Eli Lilly Export SA | |
Evista Industries, Inc.
 Evista Industries, Inc. Miscellaneous Commercial ServicesCommercial Services Evista Industries, Inc. provides environmental consulting services to the property insurance and restoration industry. It offers full survey, renovation survey, project design, project management, monitoring and clearance assessment services. The company was founded by Joseph Anthony Wright in 2005 and is headquartered in Newport Beach, CA. | Commercial Services |
| Norwest Indiana, Inc. | Finance |
